Dr. Virginia Von Schaefer and Salicinium Therapy

Although traditional forms of cancer treatment focus on chemotherapy, radiation, and surgery, there are numerous natural treatments that have proven greatly efficacious in the fight against cancer. One of these natural remedies is Salicinium, a substance that targets cancer cells’ greatly heightened level of anaerobic glycolysis to inhibit their energy production and lead to cancer cell death. As one of the world’s foremost experts in Salicinium therapy, Virginia Von Schaefer, M.D., has years of experience in the administration and efficacy of Salicinium treatment.

What Is Salicinium Therapy?

Salicinium therapy uses a glucose molecule conjoined to a benzaldehyde ring to target cancer cells without causing harm to healthy cells in the body. More specifically, Salicinium stops the process of anaerobic glycolysis, which is the pathway through which cancerous cells derive their energy to fuel their rapid growth. In addition to being a potent cancer therapy, Salicinium also shows promise as a treatment for viruses, bacteria, and other detrimental microbes which utilize anaerobic glycolysis as their primary form of energy production.

Salicinium Therapy and Chemotherapy

One of the main benefits of Salicinium treatment is that it can be utilized in conjunction with chemotherapy and other traditional cancer treatments to achieve the most optimal patient health outcomes. Although the optimal time of Salicinium administration varies from patient to patient, one of the greatest benefits of Salicinium is that after tissue saturation has been achieved through IV administration, the saturation can be maintained through the utilization of oral Salicinium. 

What Cancers Might Salicinium Treat?

Due to its molecular structure allowing it to be absorbed similarly to a molecule of glucose, Salicinium therapy shows promise for treating multiple types of cancers. As medical experts such as Dr. Virginia Von Schaefer have discovered, Salicinium therapy has shown efficacy in a wide variety of cancers, including:

• Breast cancer, which is the most prevalent type of cancer in women in the United States
• Lung cancer, which is one of the most deadly forms of cancer 
• Colon cancer, which is one of the most common cancers in the United States
• Ovarian cancer, which affects over 200,000 US women per year
• Prostate cancer, which is one of the leading causes of cancer death in men of all races

Because these are some of the most common and potentially deadly cancers in the United States, Salicinium holds great promise in its ability to treat these persistent and dangerous diseases.

About

Virginia Von Schaefer, M.D., graduated from the Columbia University Vagelos College of Physicians and Surgeons and specializes in oncology and integrative medicine. While at Columbia, she made strides in vascular research and received the Vagelos College of Physicians and Surgeons Dr. J Lattimer award for her cancer research. In addition, Dr. Von Schaefer recently gave a speech on the topic of Salicinium and has written a recent article in the Townsend paper regarding its usage.